Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT
Atara Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 171.09M | 199.73M | 128.94M | 100.44M | 62.39M | 34.7M | 8.57M | 4.54M | 6.86M | 57.48M | 63.57M | 70.9M | 71.81M | 24.1M | 20.34M | 370.98M | 365.61M | 361.74M |
Cost of Revenue | 35.39M | 39.46M | 21.01M | 17.37M | 12.39M | 10.65M | 8.89M | 9.79M | 11.32M | 73.32M | 75.33M | 74.45M | 140.64M | 144.22M | 144.59M | 320.5M | 310.04M | 303.13M |
Gross Profit | 135.7M | 160.27M | 107.93M | 83.06M | 50M | 24.05M | -313K | -5.25M | -4.46M | -15.84M | -11.76M | -3.55M | -68.83M | -120.11M | -124.25M | 50.48M | 55.57M | 58.62M |
Operating Income | 8.04M | -13.39M | -78.69M | -119.76M | -167.62M | -220.8M | -269.32M | -291.58M | -306.59M | -267.31M | -280.51M | -300.87M | -301.06M | -352.93M | -342.95M | -328.76M | -318.65M | -312.6M |
Interest Income | 1.44M | 1.74M | 2.11M | 2.22M | 2.98M | 4.23M | 5.43M | 6.71M | 6.46M | 5.47M | 3.9M | 1.91M | 932K | 228K | n/a | 398K | 762K | 1.26M |
Pretax Income | 5.76M | -15.68M | -85.42M | -133.14M | -181.03M | -233.09M | -276.11M | -290.24M | -304.51M | -214.93M | -228.29M | -247.04M | -247.62M | -349.87M | -340.1M | -328.07M | -317.75M | -311.43M |
Net Income | 5.79M | -15.64M | -371.17M | -962.98M | -1.64B | -2.33B | -2.76B | -2.9B | -3.05B | -2.15B | -2.28B | -2.47B | -2.48B | -3.5B | -3.4B | -3.28B | -3.18B | -3.11B |
Selling & General & Admin | 37.85M | 40.25M | 38.53M | 39.48M | 41.3M | 45.73M | 49.84M | 52.7M | 59.38M | 64.85M | 71.55M | 80.13M | 81.05M | 81.63M | 78.8M | 73.13M | 68.11M | 65.1M |
Research & Development | 107.39M | 133.41M | 148.09M | 163.35M | 176.31M | 199.12M | 219.17M | 237.7M | 250.97M | 259.73M | 272.53M | 289.15M | 289.33M | 292.9M | 282M | 268.42M | 257.96M | 251.05M |
Other Expenses | n/a | n/a | 68K | 56K | 29K | 19K | -246K | -234K | -207K | -197K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 145.24M | 173.66M | 186.62M | 202.83M | 217.62M | 244.85M | 269.01M | 290.4M | 310.35M | 324.58M | 344.09M | 369.28M | 370.38M | 374.54M | 360.8M | 341.55M | 326.07M | 316.15M |
Interest Expense | 2.25M | 4.48M | 4.62M | 4.77M | 4.99M | 5.1M | 5.29M | 5.08M | 3.81M | 2.56M | 1.23M | 256K | 133K | 4K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -1.36M | -2.42M | -2.42M | -2.42M | -1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 180.63M | 213.12M | 207.63M | 220.2M | 230M | 255.5M | 277.89M | 296.13M | 313.46M | 324.8M | 344.09M | 369.28M | 370.38M | 374.54M | 360.8M | 341.55M | 326.07M | 316.15M |
Income Tax Expense | -33K | -36K | -12K | 18K | 16K | 17K | 15K | 6K | 35K | -50.56M | -50.7M | -50.67M | -51.22M | -610K | -868K | -890K | -343K | -358K |
Shares Outstanding (Basic) | 12.2M | 10.76M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.1M | 4.03M | 3.9M | 3.74M | 3.68M | 3.66M |
Shares Outstanding (Diluted) | 12.31M | 10.85M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.69M | 3.66M |
EPS (Basic) | -0.39 | -3.69 | -12.87 | -25.66 | -39.13 | -52.94 | -65.27 | -69.36 | -73.49 | -52.04 | -55.93 | -61.82 | -63.9 | -91.17 | -90.71 | -90.58 | -90.87 | -96.63 |
EPS (Diluted) | -0.43 | -3.72 | -12.87 | -25.66 | -39.13 | -52.94 | -65.27 | -69.36 | -73.49 | -52.08 | -55.97 | -61.86 | -63.94 | -91.19 | -90.73 | -90.6 | -90.89 | -96.63 |
EBITDA | 13.91M | -5.74M | -75.75M | -123.21M | -170.88M | -222.96M | -263.09M | -279.32M | -294.72M | -256.89M | -274.08M | -290.71M | -290.61M | -341.6M | -331.12M | -319.74M | -309.78M | -304M |
EBIT | 6.59M | -11.2M | -80.8M | -128.37M | -176.02M | -227.96M | -270.8M | -287.07M | -302.64M | -214.31M | -229M | -246.87M | -247.72M | -350.32M | -340.46M | -328.76M | -318.65M | -312.6M |
Depreciation & Amortization | 4.13M | 5.46M | 5.05M | 5.16M | 5.13M | 7.95M | 10.66M | 13.52M | 16.45M | 16.51M | 14.64M | 13.76M | 12.47M | 10.99M | 11.36M | 10.33M | 9.65M | 8.98M |